Dihexyverine Free Base

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H413734

CAS#: 561-77-3 (free base)

Description: Dihexyverine Free Base is an antimuscarinic pharmaceutical drug related to dicycloverine used as a spasmolytic.


Chemical Structure

img
Dihexyverine Free Base
CAS# 561-77-3 (free base)

Theoretical Analysis

Hodoodo Cat#: H413734
Name: Dihexyverine Free Base
CAS#: 561-77-3 (free base)
Chemical Formula: C20H35NO2
Exact Mass: 321.27
Molecular Weight: 321.510
Elemental Analysis: C, 74.72; H, 10.97; N, 4.36; O, 9.95

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 561-77-3 (free base)   5588-25-0 (HCl)  

Synonym: Dihexyverine Free Base; BRN0247822; BRN-0247822; BRN 0247822

IUPAC/Chemical Name: (Bicyclohexyl)-1-carboxylic acid, 2-piperidinoethyl ester

InChi Key: MNSQDVCVWNXBFQ-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H35NO2/c22-19(23-17-16-21-14-8-3-9-15-21)20(12-6-2-7-13-20)18-10-4-1-5-11-18/h18H,1-17H2

SMILES Code: O=C(C1(C2CCCCC2)CCCCC1)OCCN3CCCCC3

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 321.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: FERRON M. [Preliminary clinical study on the use of dihexyverine in obstetrics]. Can Med Assoc J. 1962 Nov 24;87(21):1121-3. PMID: 13944939; PMCID: PMC1849825.

2: MEUNIER H. Sur l'emploi de la dihexyverine en gynécologie [Use of dihexyverine in gynecology]. Gaz Med Fr. 1957 Sep 25;64(18):1533-4. French. PMID: 13480436.

3: ROLLIN G. Essai de traitement des toux spasmodiques par un nouvel antispasmodique de synthèse: la dihexyverine [Trial therapy of spastic cough with a new synthetic antispasmodic: dihexyverine]. Gaz Med Fr. 1955 Dec 25;62(24):1962-3. French. PMID: 13294387.

4: DELECOUR, VITSE, MONNIER. [Clinical experimentation with an antispasmodic, "Dihexyverine", in obstetrical practice]. Lille Med. 1962 Feb;7:143-6. French. PMID: 13885120.

5: FRANCK C, GRANDPIERRE R. Action du dihexyvérine sur le bronchospasme histaminique chez le cobaye [Effect of dihexyverine on histaminic bronchospasm in guinea pigs]. Rev Pathol Gen Physiol Clin. 1955 Mar;55(666):387-9. French. PMID: 14396051.

6: SIMON C, CARRAUD G. Contribution au traitement des entéropathies; a propos des applications digestives d'un nouveau spasmolytique de synthèse: dihexyvérine [Contribution to the treatment of enteropathies; digestive application of a new synthetic spasmolytic--dihexyverine]. Sem Hop. 1955 Mar 20;31(18/2):91-3. French. PMID: 14373023.

7: FRANCOIS A. Des indications obstétricales prénatales de la dihexyvérine [Prenatal obstetric indications for dihexyverine]. Sem Hop. 1955 Sep 30;31(57):2980-3. French. PMID: 13267510.

8: FERRON M. [Preliminary clinical study on the use of dihexyverine in obstetrics]. Union Med Can. 1962 Aug;91:832-6. French. PMID: 13892604.

9: BILWEIS J. Etude expérimentale sur l'utilisation de la dihexyverine au cours du travail obstétrical dirigé selon la méthode d'accouchement physiologiquement accéléré [Experimental study on the use of dihexyverine in obstetrical labor by the physiological accelerated labor method]. Concours Med. 1958 Mar 8;80(10):1193-5. French. PMID: 13511938.

10: FRANCK C, LAMARCHE M, ROZE P. Modifications de la résistance au déficit en oxygène chez le cobaye après administration de dihexyvérine [Modifications in the resistance to oxygen deficiency in the guinea pig after administration of dihexyverine]. C R Seances Soc Biol Fil. 1955 Dec;149(23-24):2201-2. French. PMID: 13317334.